• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维帕他韦共聚维酮固体分散体的强制降解研究及HPLC-UV分析方法的开发与验证

Forced Degradation Studies and Development and Validation of HPLC-UV Method for the Analysis of Velpatasvir Copovidone Solid Dispersion.

作者信息

Zaman Bakht, Hassan Waseem, Khan Adnan, Mushtaq Ayesha, Ali Nisar, Bilal Muhammad, Ahmed Dina A

机构信息

Institute of Chemical Sciences, University of Peshawar, Peshawar 25120, Pakistan.

Department of Pharmacy, Quaid-i-Azam University, Islamabad 45320, Pakistan.

出版信息

Antibiotics (Basel). 2022 Jul 5;11(7):897. doi: 10.3390/antibiotics11070897.

DOI:10.3390/antibiotics11070897
PMID:35884151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9311562/
Abstract

Analytical methods for the drug substance and degradation products (DPs) are validated by performing forced degradation studies. Forced degradation studies of Velpatasvir (VEL) drug substance and Velpatasvir copovidone solid dispersion (VEL-CSD) were performed under the stressed alkaline, acidic, oxidative and thermal conditions according to ICH guidelines ICH Q1A (R2). VEL is labile to degrade in stressed alkaline, acidic, and oxidative conditions. It is also photolabile and degraded during photostability studies as described by ICH Q1B, and showed no degradation on exposure to extreme temperature when protected from light. A sensitive stability indicating HPLC-UV method was developed and validated for the separation of VEL and eight DPs. The DPs of VEL are separated using gradient elution of mobile phase containing 0.05% Trifluoroacetic acid (TFA) and methanol over symmetry analytical column C18 (250 mm × 4.6 mm, 5 µm) with a flow rate of 0.8 mL min. Simultaneous detection of all DPs and VEL was performed on UV detector at 305 nm. The performance parameters like precision, specificity and linearity of the method were validated using reference standards as prescribed by ICHQ2 (R1). Limits of quantification and limits of detection were determined from calibration curve using the expression 10δ/slope and 3δ/slope respectively. The proposed method is stability-indicating and effectively applied to the analysis of process impurities and DPs in VEL drug substance and VEL-CSD.

摘要

通过进行强制降解研究来验证原料药和降解产物(DPs)的分析方法。根据国际协调会议(ICH)指南ICH Q1A(R2),在碱性、酸性、氧化和热应激条件下对维帕他韦(VEL)原料药和维帕他韦共聚维酮固体分散体(VEL-CSD)进行了强制降解研究。VEL在碱性、酸性和氧化应激条件下易降解。如ICH Q1B所述,它在光稳定性研究中也对光敏感且会降解,并且在避光条件下暴露于极端温度时未显示降解。开发并验证了一种灵敏的稳定性指示高效液相色谱-紫外(HPLC-UV)方法,用于分离VEL和8种降解产物。使用含有0.05%三氟乙酸(TFA)和甲醇的流动相在Symmetry分析柱C18(250 mm×4.6 mm,5 µm)上进行梯度洗脱,流速为0.8 mL/min,以分离VEL的降解产物。在305 nm波长下用紫外检测器同时检测所有降解产物和VEL。按照ICH Q2(R1)的规定,使用参考标准对该方法的精密度、特异性和线性等性能参数进行了验证。定量限和检测限分别根据校准曲线用表达式10δ/斜率和3δ/斜率确定。所提出的方法是稳定性指示的,并有效地应用于VEL原料药和VEL-CSD中工艺杂质和降解产物的分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c9/9311562/20ec1a091e43/antibiotics-11-00897-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c9/9311562/71cea44902c8/antibiotics-11-00897-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c9/9311562/1f83309e468b/antibiotics-11-00897-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c9/9311562/3f89795a7690/antibiotics-11-00897-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c9/9311562/46ba301d99b3/antibiotics-11-00897-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c9/9311562/20ec1a091e43/antibiotics-11-00897-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c9/9311562/71cea44902c8/antibiotics-11-00897-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c9/9311562/1f83309e468b/antibiotics-11-00897-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c9/9311562/3f89795a7690/antibiotics-11-00897-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c9/9311562/46ba301d99b3/antibiotics-11-00897-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c9/9311562/20ec1a091e43/antibiotics-11-00897-g002.jpg

相似文献

1
Forced Degradation Studies and Development and Validation of HPLC-UV Method for the Analysis of Velpatasvir Copovidone Solid Dispersion.维帕他韦共聚维酮固体分散体的强制降解研究及HPLC-UV分析方法的开发与验证
Antibiotics (Basel). 2022 Jul 5;11(7):897. doi: 10.3390/antibiotics11070897.
2
Identification, characterization, and in silico ADMET prediction of nirmatrelvir and its degradation products using HPLC-PDA and LC-QTOF-MS/MS.采用 HPLC-PDA 和 LC-QTOF-MS/MS 对奈玛特韦及其降解产物进行鉴定、表征和计算机 ADMET 预测。
Rapid Commun Mass Spectrom. 2024 Oct 30;38(20):e9896. doi: 10.1002/rcm.9896.
3
Development of stability-indicating method for separation and characterization of benidipine forced degradation products using LC-MS/MS.采用液相色谱-串联质谱法开发用于分离和表征贝尼地平强制降解产物的稳定性指示方法。
Biomed Chromatogr. 2023 Jan;37(1):e5517. doi: 10.1002/bmc.5517. Epub 2022 Oct 21.
4
Stress degradation studies on varenicline tartrate and development of a validated stability-indicating HPLC method.酒石酸伐尼克兰的应力降解研究及一种经过验证的稳定性指示高效液相色谱法的开发。
Sci Pharm. 2012 Jan-Mar;80(1):115-26. doi: 10.3797/scipharm.1109-22. Epub 2011 Dec 5.
5
Selective separation, detection of zotepine and mass spectral characterization of degradants by LC-MS/MS/QTOF.通过液相色谱-串联质谱/四极杆飞行时间质谱进行佐替平的选择性分离、检测及降解产物的质谱表征
J Pharm Anal. 2014 Apr;4(2):107-116. doi: 10.1016/j.jpha.2013.04.002. Epub 2013 May 28.
6
Selective separation and characterisation of stress degradation products and process impurities of prucalopride succinate by LC-QTOF-MS/MS.采用液相色谱-四极杆飞行时间串联质谱法(LC-QTOF-MS/MS)对琥珀酸普芦卡必利的应激降解产物和工艺杂质进行选择性分离与表征。
J Pharm Biomed Anal. 2016 Jun 5;125:219-28. doi: 10.1016/j.jpba.2016.03.047. Epub 2016 Mar 24.
7
Characterization of Forced Degradation Products of Netarsudil: Optimization and Validation of a Stability-Indicating RP-HPLC Method for Simultaneous Quantification of Process-Related Impurities.奈他地尔强制降解产物的表征:用于同时定量工艺相关杂质的稳定性指示反相高效液相色谱法的优化与验证
Turk J Pharm Sci. 2024 Jul 12;21(3):224-233. doi: 10.4274/tjps.galenos.2023.99148.
8
LC and LC-MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway.LC 和 LC-MS/MS 研究鉴定和表征依鲁替尼的新降解产物,并阐明其降解途径。
J Pharm Biomed Anal. 2021 Feb 5;194:113768. doi: 10.1016/j.jpba.2020.113768. Epub 2020 Nov 20.
9
Development and Validation of Fast and Sensitive RP-HPLC Stability-Indicating Method for Quantification of Piroxicam in Bulk Drug.用于原料药中吡罗昔康定量的快速灵敏反相高效液相色谱稳定性指示方法的开发与验证
J Chromatogr Sci. 2025 Jan 9;63(1). doi: 10.1093/chromsci/bmae021.
10
Development of a Forced Degradation Profile of Alosetron by Single Mode Reversed-Phase HPLC, LC-MS, and its Validation.通过单模反相高效液相色谱法、液相色谱-质谱联用技术建立阿洛司琼强制降解图谱及其验证
Sci Pharm. 2014 Dec 29;83(2):311-20. doi: 10.3797/scipharm.1411-07. Print 2015 Apr-Jun.

引用本文的文献

1
Quality by design based ecofriendly HPLC analytical method for simultaneous quantification of erastin and lenalidomide in mesoporous silica nanoparticles.基于质量源于设计的环保型高效液相色谱分析方法,用于同时定量测定介孔二氧化硅纳米颗粒中的埃拉斯汀和来那度胺。
Sci Rep. 2025 Mar 14;15(1):8873. doi: 10.1038/s41598-025-93331-8.

本文引用的文献

1
Nanoparticles as delivery vehicles for antiviral therapeutic drugs.纳米颗粒作为抗病毒治疗药物的递送载体。
Eng Regen. 2021;2:31-46. doi: 10.1016/j.engreg.2021.03.001. Epub 2021 Mar 24.
2
Selective and sensitive spectrofluorimetric quantification of velpatasvir in presence of sofosbuvir. Application to their co-formulated tablet.在索磷布韦存在的情况下对维帕他韦进行选择性和灵敏的荧光光谱定量分析。应用于它们的复方片剂。
RSC Adv. 2018 Sep 24;8(57):32909-32915. doi: 10.1039/c8ra06588h. eCollection 2018 Sep 18.
3
New Treatments for Chronic Hepatitis B Virus/Hepatitis D Virus Infection.
慢性乙型肝炎/丁型肝炎病毒感染的新治疗方法。
Clin Liver Dis. 2021 Nov;25(4):831-839. doi: 10.1016/j.cld.2021.06.011. Epub 2021 Aug 8.
4
dissolution of poorly water-soluble drugs: Proof of concept based on fluorescence bioimaging.难溶性药物的溶解:基于荧光生物成像的概念验证
Acta Pharm Sin B. 2021 Apr;11(4):1056-1068. doi: 10.1016/j.apsb.2020.08.002. Epub 2020 Aug 13.
5
Two novel UPLC methods utilizing two different analytical columns and different detection approaches for the simultaneous analysis of velpatasvir and sofosbuvir: application to their co-formulated tablet.两种利用不同分析柱和不同检测方法同时分析维帕他韦和索磷布韦的新型超高效液相色谱法:应用于它们的复方片剂。
BMC Chem. 2019 Sep 30;13(1):118. doi: 10.1186/s13065-019-0635-2. eCollection 2019 Dec.
6
Spectrophotometric assessment of the brand new antiviral combination: Sofosbuvir and velpatasvir in their pure forms and pharmaceutical formulation.分光光度法评估全新抗病毒组合:索磷布韦和维帕他韦在纯品和药物制剂中的应用。
Spectrochim Acta A Mol Biomol Spectrosc. 2019 Apr 15;213:159-166. doi: 10.1016/j.saa.2019.01.058. Epub 2019 Jan 16.
7
Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial.索磷布韦/维帕他韦治疗亚洲慢性丙型肝炎病毒感染:一项单臂、开放标签、3 期临床试验。
Lancet Gastroenterol Hepatol. 2019 Feb;4(2):127-134. doi: 10.1016/S2468-1253(18)30343-1. Epub 2018 Dec 14.
8
Study on fluorescence properties of HCV antiviral (velpatasvir) and its fluorimetric determination in presence of sofosbuvir; application to stability study and human plasma.丙型肝炎病毒抗病毒药物(维帕他韦)的荧光性质及其在索磷布韦存在下的荧光测定研究;在稳定性研究和人血浆中的应用
Luminescence. 2018 Nov;33(7):1249-1256. doi: 10.1002/bio.3542. Epub 2018 Aug 24.
9
Development of forced degradation and stability indicating studies of drugs-A review.药物强制降解及稳定性指示研究的进展——综述
J Pharm Anal. 2014 Jun;4(3):159-165. doi: 10.1016/j.jpha.2013.09.003. Epub 2013 Sep 17.
10
Pharmaceutical impurities and degradation products: uses and applications of NMR techniques.药物杂质与降解产物:核磁共振技术的用途与应用
J Pharm Biomed Anal. 2014 Dec;101:102-22. doi: 10.1016/j.jpba.2014.04.016. Epub 2014 Apr 24.